Orphan Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage:by Active ingredients (Obinutuzumab, Lenalidomide, Brentuximab, Vedotin, Riociguat, Ofatumumab, Nelarabine, Bosutinib, Mannitol, Carglumic acid, Aztreonam, Histamine hydrochloride, Eliglustat, Cabozantinib, Ramucirumab, Decitabine, Defibrotide) ; Disease (Hodgkin lymphoma, Paroxysmal nocturnal hemoglobinuria, Chronic thromboembolic pulmonary hypertension (CTEPH) , Chronic lymphocytic leukemia, Chronic Myeloid Leukaemia, T-cell acute lymphoblastic leukemia (T-ALL) , Philadelphia chromosome positive chronic myelogenous leukaemia (Ph+ CML) , Cystic fibrosis (CF) , acute myeloid leukaemia, Multiple Myeloma, Isovaleric acidaemia, Gaucher disease type 1 (GD1) , Metastatic medullary thyroid carcinoma, Advanced gastric cancer or gastro-esophageal junction adenocarcinoma, Secondary Acute myeloid leukemia (AML) , Severe hepatic venoocclusive disease (VOD) / sinusoidal obstructive syndrome (SOS) ) ; End User (Hospitals, Ambulatory Surgical Centers) , and Geography (North America, Europe, Asia Pacific, and South and Central America)